Search - tctmd.com

Displaying 1 - 20 of 73

Sort: Relevancy | Date

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

TCT 72: Short and Medium-term Clinical Outcome of Amphilimus Polymer-Free Drug-Eluting Stent in Diabetic Patients: An All-Comers Multicenter Spanish Registry (Control-8 Registry)

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Antonio Gomez Menchero

October 31, 2016

News Industry News

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

October 31, 2016

Presentation TCT 2016

B Braun - ISAR Coroflex

Presenter: Marie-Claude Morice, Christian Hengstenberg

October 31, 2016

Presentation TCT 2016

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

Alvimedica - Cre8: Design Specifications and Results

Presenter: Marie-Claude Morice, Gennaro Sardella

October 31, 2016

Presentation TCT 2016

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Presenter: Marie-Claude Morice, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

Presenter: Marie-Claude Morice, Stephen G. Worthley

October 31, 2016

Presentation TCT 2016

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

Presenter: David W.M. Muller, Jonathan M. Hill, Philip M. Urban

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

Advertisement

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

TCT 72: Short and Medium-term Clinical Outcome of Amphilimus Polymer-Free Drug-Eluting Stent in Diabetic Patients: An All-Comers Multicenter Spanish Registry (Control-8 Registry)

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

B Braun - ISAR Coroflex

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Alvimedica - Cre8: Design Specifications and Results

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

LEADERS FREE: Two-Year Clinical and Subgroup Outcomes From a Prospective, Randomized Trial of a Polymer-Free Drug-Coated Stent and a Bare Metal Stent in Patients With Coronary Artery Disease at High Bleeding Risk

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content